KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)
NCT02777567
·
clinicaltrials.gov ↗
COMPLETED
Status
315
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Sponsor
AstraZeneca